NCT00458952 2016-07-13Phase 1 Study of Iobenguane (MIBG) I 131 in Patients With Malignant Pheochromocytoma/ParagangliomaMolecular Insight Pharmaceuticals, Inc.Phase 1/2 Completed24 enrolled 8 charts